Skip to main content
Caplight Logo









VyCAP

VyCAP

Private
DeventerHealthcare & Life Scienceshttps://vycap.com

Last Round

Seed

Feb 19, 2016

Company Overview

VyCAP is a medical technology company that develops and manufactures innovative solutions for the isolation, identification, and analysis of cells from biological fluid samples.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

single-cell isolationcirculating tumor cellsCTCliquid biopsybiotech equipmentmicro-electro-mechanical systemsMEMScell analysisrare cell analysisrazor-and-bladeslaboratory automationfiltration technologysingle-cell analysisoncology researchlab hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VyCAP Comparables

Compare VyCAP with similar companies based on industry and business-model similarity.

VyCAP comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cell Microsystems
80%
CelLBxHealth plc
77%
RareCyte
77%

VyCAP Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 19, 2016

VyCAP Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 28, 2024

    Monthly visitors grew 93% MoM, reaching 1.2K.

  • Feb 19, 2016

    Seed round with participation from Oost NL and High Tech Funds.

VyCAP Filings

Explore SEC and related filing metadata, where available.

VyCAP filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about VyCAP's valuation, stock price, and market status.

Is VyCAP a public or private company?

VyCAP is a private company.

What is the current stock price of VyCAP?

VyCAP is a private company with no public stock price. No recent secondary market data is available.

How much is VyCAP worth (valuation)?

Valuation information for VyCAP is not publicly available.

Can I buy VyCAP stock?

VyCAP shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was VyCAP's last funding round?

VyCAP's most recent funding round was Seed on February 19, 2016.

Who are the main investors in VyCAP?

Key investors in VyCAP include High Tech Funds, East Netherlands Development Agency (Oost NL).

Will VyCAP IPO soon?

No public IPO plans have been announced for VyCAP.

How can I track VyCAP secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VyCAP's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDeventer
Employee Range1
Year Founded2011
Last FundingFeb 19, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?